Qiong Lyu

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Integration of single-cell transcriptomics and genomic mutation analysis identifies an immunotherapy-resistant tumor subcluster and validates ARNTL2 as a malignant driver in lung adenocarcinoma.

Integration of single-cell transcriptomics and genomic mutation analysis identifies an immunotherapy-resistant tumor subcluster and validates ARNTL2 as a malignant driver in lung adenocarcinoma.

Journal: Translational oncology

Published: June 12, 2026

Molecular subtyping of small-cell lung cancer in clinical practice: Primary tumor-lymph node concordance, intratumoral heterogeneity, and genomic context in a Chinese cohort.

Molecular subtyping of small-cell lung cancer in clinical practice: Primary tumor-lymph node concordance, intratumoral heterogeneity, and genomic context in a Chinese cohort.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 14, 2025

TGM2-TUFM promotes acquired resistance to EGFR-TKIs in EGFR-mutated NSCLC through p62-mediated lipophagy.

TGM2-TUFM promotes acquired resistance to EGFR-TKIs in EGFR-mutated NSCLC through p62-mediated lipophagy.

Journal: Respiratory research

Published: November 08, 2025

ALDH1L2 induces resistance to chemotherapy in small cell lung cancer by inhibiting ferroptosis.

ALDH1L2 induces resistance to chemotherapy in small cell lung cancer by inhibiting ferroptosis.

Journal: Redox biology

Published: August 26, 2025

PPP2R2C confers radioresistance in nasopharyngeal carcinoma by suppressing ferroptosis via RPS27L stabilization.

PPP2R2C confers radioresistance in nasopharyngeal carcinoma by suppressing ferroptosis via RPS27L stabilization.

Journal: Cell death & disease

Published: July 16, 2025

Multi-trait association analysis reveals shared genetic architecture between lung cancer and cardiometabolic diseases.

Multi-trait association analysis reveals shared genetic architecture between lung cancer and cardiometabolic diseases.

Journal: iScience

Published: July 10, 2025

KDM4B/DHX9 promotes chemoresistance in small-cell lung cancer through the MYCN-driven signaling pathway.

KDM4B/DHX9 promotes chemoresistance in small-cell lung cancer through the MYCN-driven signaling pathway.

Journal: Oncogene

Published: May 29, 2025

Druggable targets for Parkinson's disease: transcriptomics based Mendelian randomization study.

Druggable targets for Parkinson's disease: transcriptomics based Mendelian randomization study.

Journal: Scientific reports

Published: February 19, 2024

HMGB1 promotes chemoresistance in small cell lung cancer by inducing PARP1-related nucleophagy.

HMGB1 promotes chemoresistance in small cell lung cancer by inducing PARP1-related nucleophagy.

Journal: Journal of advanced research

Published: August 21, 2023

METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy.

METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy.

Journal: Journal of experimental & clinical cancer research : CR

Published: October 10, 2022

Relationship between ATOH1 and tumor microenvironment in colon adenocarcinoma patients with different microsatellite instability status.

Relationship between ATOH1 and tumor microenvironment in colon adenocarcinoma patients with different microsatellite instability status.

Journal: Cancer cell international

Published: April 23, 2022

Applications of Machine Learning to Predict Cisplatin Resistance in Lung Cancer.

Applications of Machine Learning to Predict Cisplatin Resistance in Lung Cancer.

Journal: International journal of general medicine

Published: July 21, 2021

Showing 1-12 of 15

Last Updated: 09/26/2026